Defying death: the hepatocyte's survival kit

被引:22
作者
Schoemaker, MH
Moshage, H
机构
[1] Univ Groningen Hosp, Ctr Liver Digest & Metab Dis, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Inst Drug Explorat, Dept Therapeut Gene Modulat, NL-9700 AC Groningen, Netherlands
关键词
apoptosis; cell death; hepatocyte; liver injury; survival; stellate cell; therapeutic intervention;
D O I
10.1042/CS20040090
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Acute liver injury can develop as a consequence of viral hepatitis, drug- or toxin-induced toxicity or rejection after liver transplantation, whereas chronic liver injury can be due to long-term exposure to alcohol, chemicals, chronic viral hepatitis, metabolic or cholestatic disorders. During liver injury, liver cells are exposed to increased levels of cytokines, bile acids and oxidative stress. This results in death of hepatocytes. In contrast, stellate cells become active and are resistant against cell death. Eventually, acute and chronic liver injury is followed by loss of liver function for which no effective therapies are available. Hepatocytes are well equipped with protective mechanisms to prevent cell death. As long as these protective mechanisms can be activated, the balance will be in favour of cell survival. However, the balance between cell survival and cell death is delicate and can be easily tipped towards cell death during liver injury. Therefore understanding the cellular mechanisms controlling death of liver cells is of clinical and scientific importance and can lead to the identification of novel intervention targets. This review describes some of the mechanisms that determine the balance between cell death and cell survival during liver diseases. The strict regulation of apoptotic cell death allows therapeutic intervention strategies. In this light, receptor-mediated apoptosis and mitochondria-mediated cell death are discussed and strategies are provided to selectively interfere with these processes.
引用
收藏
页码:13 / 25
页数:13
相关论文
共 146 条
[1]   Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2 [J].
Adrain, C ;
Creagh, EM ;
Martin, SJ .
EMBO JOURNAL, 2001, 20 (23) :6627-6636
[2]   A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis [J].
Arvelo, MB ;
Cooper, JT ;
Longo, C ;
Daniel, S ;
Grey, ST ;
Mahiou, J ;
Czismadia, E ;
Abu-Jawdeh, G ;
Ferran, C .
HEPATOLOGY, 2002, 35 (03) :535-543
[3]   Differential protection with inhibitors of caspase-8 and caspase-3 in murine models of tumor necrosis factor and Fas receptor-mediated hepatocellular apoptosis [J].
Bajt, ML ;
Vonderfecht, SL ;
Jaeschke, H .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2001, 175 (03) :243-252
[4]   An essential role for NF-kappa B in preventing TNF-alpha-induced cell death [J].
Beg, AA ;
Baltimore, D .
SCIENCE, 1996, 274 (5288) :782-784
[5]   The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue [J].
Beljaars, L ;
Weert, B ;
Geerts, A ;
Meijer, DKF ;
Poelstra, K .
BIOCHEMICAL PHARMACOLOGY, 2003, 66 (07) :1307-1317
[6]  
Bellas RE, 1997, AM J PATHOL, V151, P891
[7]  
Beyaert R, 2002, INT REV CYTOL, V214, P225
[8]   Tumor necrosis factor α-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis [J].
Bohan, A ;
Chen, WS ;
Denson, LA ;
Held, MA ;
Boyer, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (38) :36688-36698
[9]   Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer [J].
Bortolami, M ;
Venturi, C ;
Giacomelli, L ;
Scalerta, R ;
Bacchetti, S ;
Marino, F ;
Floreani, A ;
Lise, M ;
Naccarato, R ;
Farinati, F .
DIGESTIVE AND LIVER DISEASE, 2002, 34 (11) :794-801
[10]   The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release [J].
Bradham, CA ;
Qian, T ;
Streetz, K ;
Trautwein, C ;
Brenner, DA ;
Lemasters, JJ .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (11) :6353-6364